Journal of Addiction Medicine
Scope & Guideline
Exploring Innovations in Addiction Research
Introduction
Aims and Scopes
- Substance Use Disorders and Treatment:
The journal publishes studies on various substance use disorders including alcohol, opioids, stimulants, and emerging substances. It emphasizes the effectiveness of pharmacological and non-pharmacological treatments, including medication-assisted treatment (MAT) and behavioral interventions. - Epidemiology and Public Health:
Research examining the prevalence, risk factors, and public health implications of substance use disorders is a key focus. This includes studies on trends in substance use, overdose rates, and the impact of socio-economic factors on addiction. - Harm Reduction Strategies:
The journal supports the dissemination of research on harm reduction approaches, such as safe injection sites, naloxone distribution, and education on safer substance use practices. - Policy Analysis and Health Systems:
Analysis of policies affecting addiction treatment access, insurance coverage, and health care systems is a consistent theme. The journal seeks to inform policymakers and healthcare providers about best practices and areas for improvement. - Special Populations:
Research focusing on specific populations, including women, veterans, adolescents, and marginalized communities, is highlighted to understand unique challenges and treatment needs. - Mental Health and Co-occurring Disorders:
The intersection of mental health issues and substance use disorders is a critical area of exploration, highlighting the need for integrated treatment approaches.
Trending and Emerging
- Telehealth and Remote Care:
With the rise of telemedicine, especially during the COVID-19 pandemic, there has been a significant increase in research exploring the effectiveness and implementation of remote care strategies for addiction treatment. - Polysubstance Use and Its Implications:
Research focused on the co-use of multiple substances, particularly in the context of the opioid crisis and the emergence of synthetic drugs, has gained prominence, highlighting the complexity of treatment strategies required. - Social Determinants of Health:
There is a growing emphasis on understanding how social determinants, such as housing, employment, and education, affect substance use and treatment outcomes, leading to more comprehensive care models. - Integration of Mental Health with Addiction Treatment:
The integration of mental health services with addiction treatment has become a critical area of focus, recognizing the comorbidity of mental health disorders and substance use. - Innovative Harm Reduction Techniques:
Emerging harm reduction strategies, such as supervised consumption sites and the distribution of fentanyl test strips, are increasingly being researched and discussed, reflecting a shift towards more progressive approaches to addiction care. - Research on Emerging Substances:
Increased research on new psychoactive substances (NPS), such as kratom and synthetic cannabinoids, is becoming more common as these substances present unique challenges in treatment and public health.
Declining or Waning
- Traditional Substance Use Treatment Models:
There is a noticeable decline in research focused solely on traditional treatment models without considering integrated or holistic approaches. The shift towards comprehensive care that includes mental health and social determinants of health has overshadowed these older models. - Stigmatization of Substance Use:
While stigma remains a relevant topic, the frequency of studies solely focused on stigma without practical solutions or interventions has decreased. The journal now emphasizes actionable strategies to reduce stigma in clinical settings. - Alcohol Use and Dependency Research:
Research specifically targeting alcohol dependency has seen a reduction in volume compared to opioid and polysubstance use studies, possibly due to the growing urgency surrounding the opioid crisis and emerging substances. - Clinical Guidelines Without Empirical Support:
There has been a waning interest in publishing clinical guidelines or recommendations that lack robust empirical evidence. The journal has moved towards prioritizing studies with strong methodological backing. - Isolated Case Studies:
The prevalence of isolated case studies without broader implications or connections to larger trends in addiction medicine has decreased, as the journal seeks to publish studies that contribute to generalizable knowledge.
Similar Journals
Journal of Dual Diagnosis
Integrating care for a healthier tomorrow.The Journal of Dual Diagnosis, published by Routledge Journals, Taylor & Francis Ltd, is a leading interdisciplinary platform dedicated to the critical study of co-occurring mental health and substance use disorders. With its ISSN 1550-4263 and E-ISSN 1550-4271, this esteemed journal has been at the forefront of advancing research and clinical practice since its inception in 2004, and continues to serve as a vital resource until 2024. Ranked in the second quartile (Q2) in Psychiatry and Mental Health and positioned at the 64th percentile in the Scopus rankings, it emphasizes the importance of integrating care across various domains of health. Although not open access, it offers a wealth of peer-reviewed articles, case studies, and reviews suitable for researchers, practitioners, and students alike, aiming to enhance our understanding and treatment of dual diagnosis. The journal's commitment to addressing the complexities of dual disorders not only informs research but also shapes policy and clinical guidelines, making it an essential read for anyone involved in these critical areas of mental health.
Current Addiction Reports
Illuminating the path to understanding addiction.Current Addiction Reports, published by SPRINGERNATURE, is a leading journal dedicated to the comprehensive study of addiction in its various dimensions, with a particular focus on the latest clinical developments and research in Clinical Psychology and Psychiatry and Mental Health. Since its inception in 2014 and through to 2024, the journal has established itself as a pivotal resource for researchers, professionals, and students alike, currently holding a prestigious Q1 ranking in both relevant categories. With an impressive Scopus rank of #46 in Clinical Psychology and #129 in Psychiatry and Mental Health, it occupies a significant position within the field, reflecting its commitment to high-quality scholarship and impactful findings. The journal offers open access options, ensuring that vital research is readily available to a global audience. By fostering a deeper understanding of addiction trends and innovative treatment methodologies, Current Addiction Reports plays an essential role in advancing knowledge and improving clinical practices.
Adicciones
Empowering clinicians and researchers in addiction studies.Adicciones is a prominent academic journal dedicated to the fields of Medicine and Psychiatry, focusing on the multi-faceted issues surrounding addiction and substance use. Published by SOCIDROGALCOHOL in Spain, this journal has been a critical resource for researchers, clinicians, and students since its inception in 1994, with a commitment to advancing knowledge in addiction science for the benefit of public health. With an impressive impact factor that places it in the Q3 category of both Medicine (Miscellaneous) and Psychiatry and Mental Health according to 2023 rankings, Adicciones is recognized for its high-quality peer-reviewed articles that contribute to the ongoing dialogue in these vital fields. Although not currently an open-access journal, it provides valuable subscription-based access to its extensive repository of research findings and reviews, fostering a deeper understanding of the complex dynamics of addiction. The journal's continued relevance is underscored by its convergence into 2024, promising ongoing contributions that inspire new ideas and practices to combat addiction.
Addiction Science & Clinical Practice
Empowering research to reshape addiction science.Addiction Science & Clinical Practice is a premier open-access journal dedicated to advancing the understanding and treatment of addiction through evidence-based research and clinical practice. Published by BMC in the United Kingdom since 2007, this journal has significantly impacted the fields of Clinical Psychology, Medicine, and Psychiatry and Mental Health, proudly securing a Q1 ranking in multiple categories as of 2023. With an emphasis on high-quality research, the journal provides an inclusive platform for the dissemination of innovative findings and clinical insights that address the complexities of addiction. Researchers, practitioners, and students alike benefit from its unrestricted access since 2012, allowing for widespread dissemination of knowledge. Located at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to lead the way in fostering collaboration and informing best practices in addiction science.
Journal of Substance Use & Addiction Treatment
Empowering research, enhancing treatment.Journal of Substance Use & Addiction Treatment is a premier scholarly publication dedicated to advancing the understanding and treatment of substance use disorders and addictive behaviors. Published by Elsevier Science Inc, this journal serves as a vital platform for researchers, clinicians, and students in the fields of psychology, psychiatry, public health, and addiction studies. With its commitment to Open Access, the journal facilitates wide dissemination of cutting-edge research, enabling practitioners and policymakers to access critical findings that inform treatment approaches and public health strategies. As an essential resource in addiction treatment and research, the Journal of Substance Use & Addiction Treatment aims to foster interdisciplinary collaboration and innovation, ultimately improving outcomes for individuals affected by addiction.
Substance Abuse-Research and Treatment
Advancing understanding of substance use and mental health.Substance Abuse: Research and Treatment is a premier open-access journal published by SAGE Publications Ltd, focusing on the multifaceted aspects of substance use and its impact on mental health. Since its establishment in 2008, this journal has been dedicated to disseminating innovative research findings, case studies, and reviews that enhance understanding and treatment of substance-related disorders. With an impact factor that reflects its standing in the field, currently ranked in the Q2 category of Psychiatry and Mental Health, Substance Abuse: Research and Treatment strives to foster interdisciplinary dialogue among researchers, practitioners, and students. By making its content freely accessible, the journal encourages widespread engagement and application of evidence-based practices to mitigate substance abuse issues. The journal’s diverse global perspectives make it a vital resource for anyone invested in advancing knowledge and improving treatment outcomes in this critical area of public health.
Sucht-Zeitschrift fur Wissenschaft und Praxis
Bridging research and practice in addiction studies.Sucht-Zeitschrift für Wissenschaft und Praxis, published by HOGREFE AG in Switzerland, is a pivotal journal addressing the interrelated fields of addiction science and mental health. With an ISSN of 0939-5911 and an E-ISSN of 1664-2856, this journal has been dedicated to fostering interdisciplinary research and practical applications since its inception in 1991, continuing through to 2024. As a respected source in the field, it holds a 2023 Q3 quartile ranking in Medicine (miscellaneous), a Q4 ranking in Psychiatry and Mental Health, and a Q3 ranking in Public Health, highlighting its broad relevance and growing impact on contemporary health discussions. While currently not offering open access options, the journal provides a rich platform for researchers, practitioners, and students to share and gain insights into innovative practices and scientific findings that advance the understanding of addiction and its societal implications. With its contributions indexed in Scopus and a variety of rankings reflective of its quality, Sucht-Zeitschrift für Wissenschaft und Praxis serves as an essential resource for those committed to advancing knowledge and practice in addiction-related fields.
Annals of Clinical Psychiatry
Illuminating the Path to Better Mental Health Outcomes.Annals of Clinical Psychiatry, published by QUADRANT HEALTHCOM INC, is a leading journal in the fields of Medicine and Psychiatry & Mental Health. With its longstanding commitment to advancing clinical knowledge since 1989, this esteemed journal contributes invaluable insights into current psychiatric practices and mental health research. The journal is recognized in the Scopus ranking with a position in the 34th percentile, reflective of its focused scope and substantial academic contributions. While access to the journal is tailored for professionals and researchers, the absence of Open Access highlights the journal's dedication to maintaining quality and rigorous peer-reviewed standards. As part of the Q3 quartile for both Medicine and Psychiatry categories in 2023, Annals of Clinical Psychiatry serves as an essential resource for those dedicated to improving mental health outcomes, making it a vital platform for practitioners, researchers, and students alike. Situated in Parsippany, New Jersey, the journal remains a pivotal entity that fosters scholarly dialogue and exploration in clinical psychiatry.
DRUG AND ALCOHOL DEPENDENCE
Pioneering research in drug and alcohol dependence.Drug and Alcohol Dependence is a premier journal published by Elsevier Ireland Ltd, dedicated to the rigorous exploration and analysis of substance use disorders, including drug and alcohol dependencies. With its established history since 1975 and a remarkable convergence of research extending to 2024, the journal holds a prestigious position within the academic community, evidenced by its Q1 ranking in multiple categories, including Pharmacology, Psychiatry and Mental Health, and Toxicology for 2023. It ranks impressively among its peers, underscored by Scopus rankings of #46, #99, and #27 in key fields related to medical pharmacology and toxicology. As a non-open access title, it caters to a global readership of researchers, professionals, and students, providing them with peer-reviewed insights into critical developments and innovative methodologies in the field. The journal’s commitment to advancing knowledge and understanding of drug and alcohol dependence is essential for addressing the global challenges posed by substance use, making it a valuable resource for all stakeholders in public health and clinical practice.
DRUG AND ALCOHOL REVIEW
Transforming research into impactful practices.DRUG AND ALCOHOL REVIEW, published by Wiley, is a leading journal dedicated to advancing the scholarship in the fields of drug and alcohol research. Since its inception in 1989, this esteemed publication has provided a critical platform for the dissemination of innovative research findings, reviews, and theoretical papers, addressing pressing issues in substance use and addiction. With an impact factor that places it in the Q1 category in both Health (social science) and Medicine (miscellaneous), it ranks #78 out of 371 in the Scopus index for Health and #115 out of 398 in Medicine, reflecting its significant influence and high citation rates among scholars. The journal is committed to fostering a multidisciplinary approach, integrating perspectives from psychology, sociology, public health, and medicine, to inform policy and practice. Accessible to researchers and practitioners alike, *DRUG AND ALCOHOL REVIEW* serves as an essential resource for anyone invested in understanding and addressing the complexities of drug and alcohol use in society.